Jane Street Group LLC Increases Holdings in Koninklijke Philips (NYSE:PHG)

Jane Street Group LLC boosted its stake in shares of Koninklijke Philips (NYSE:PHG - Free Report) by 787.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 128,686 shares of the technology company's stock after acquiring an additional 114,193 shares during the quarter. Jane Street Group LLC's holdings in Koninklijke Philips were worth $4,211,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Kitching Partners LLC grew its holdings in Koninklijke Philips by 3.4% in the 2nd quarter. Kitching Partners LLC now owns 10,802 shares of the technology company's stock worth $272,000 after acquiring an additional 356 shares during the last quarter. Holderness Investments Co. grew its stake in shares of Koninklijke Philips by 3.4% in the second quarter. Holderness Investments Co. now owns 16,807 shares of the technology company's stock worth $424,000 after purchasing an additional 546 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Koninklijke Philips by 7.3% in the second quarter. EverSource Wealth Advisors LLC now owns 8,084 shares of the technology company's stock worth $204,000 after purchasing an additional 550 shares during the last quarter. Roof Eidam Maycock Peralta LLC increased its holdings in Koninklijke Philips by 3.4% during the 2nd quarter. Roof Eidam Maycock Peralta LLC now owns 23,964 shares of the technology company's stock valued at $604,000 after purchasing an additional 789 shares during the period. Finally, State Street Corp raised its position in Koninklijke Philips by 1.0% during the 3rd quarter. State Street Corp now owns 82,518 shares of the technology company's stock valued at $2,809,000 after purchasing an additional 844 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Jefferies Financial Group upgraded Koninklijke Philips from an "underperform" rating to a "hold" rating in a research report on Tuesday, October 29th. StockNews.com cut shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a report on Thursday, November 14th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold".

Koninklijke Philips Stock Down 1.2 %

PHG traded down $0.30 on Wednesday, hitting $24.71. The company had a trading volume of 1,106,984 shares, compared to its average volume of 942,656. The stock has a fifty day simple moving average of $27.72 and a 200-day simple moving average of $28.16. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. The firm has a market capitalization of $23.23 billion, a P/E ratio of -58.83, a P/E/G ratio of 0.92 and a beta of 0.76. Koninklijke Philips has a 52-week low of $19.55 and a 52-week high of $32.91.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.